Highlights•The seroprevalence of SARS-CoV-2 antibodies in Brazil in 2020 was 11%.•Seroprevalence increased with time, 1% in the first and 83% in the last quarter of the year.•Seroprevalence was higher in the Northern region, decreasing as one moves south.